Articles that mention Bristol-Myers Squibb -BoardProspects

Bristol-Myers Squibb

0 Comments Leave a Comment

1-17 of 17
1. Mentioned In 17 Articles
2. Why the Corporate Earnings Boom Has Failed to Lift Investors' Spirits
  
  Explore Stock Market Quotes and News Nov 18 2018 BoardBlogs
  
  ... scooping up shares of companies whose potential to generate growth looks promising, like Starbucks Corp. and Bristol-Myers Squibb Co., while trimming their holdings of United Parcel Service Inc. Starbucks delivered doub...
  Read Full Article
  
  Comment
  
  Mentions: Technology Investors Bill Ackman
3. Palleon Pharmaceuticals Appoints Lori Hu of Vertex Ventures HC to Board of Directors
  
  Explore businesswire.com Jun 21 2018 BoardMoves
  
  ... in biotechnology, medical devices and digital health. Prior to Vertex, she worked in business development at Bristol-Myers Squibb. Ms. Hu has also worked with SR One, the corporate venture capital arm of GlaxoSmithKline...
  Read Full Article
  
  Comment
  
  Mentions: Bristol-Myers Squibb MBA Vertex
4. Quest Diagnostics adds Helen Torley to Board of Directors
  
  Explore gurufocus.com May 17 2018 BoardMoves
  
  ...esses, as well as in other management positions, at Amgen Inc.; and in various senior management positions at Bristol-Myers Squibb and Sandoz/Novartis; and was in medical practice as a senior registrar in rheumatology at...
  Read Full Article
  
  Comment
  
  Mentions: Independent Director Annual Meeting Bristol-Myers Squibb
5. Which Big Pharma CEOs Least Deserved Their Big Pay Increases?
  
  Explore Fool.com Apr 4 2018 BoardBlogs
  
  ...rsky didn't get a salary bump at all last year, although he certainly wasn't hurting, raking in $1.6 million. Bristol-Myers Squibb CEO Giovanni Caforio and Gilead Sciences CEO John Milligan enjoyed the heftiest pay raise...
  Read Full Article
  
  Comment
  
  Mentions: Management Bristol-Myers Squibb Amgen
6. AVROBIO, Inc. Appoints Annalisa Jenkins to its Board of Directors
  
  Explore businesswire.com Apr 4 2018 BoardMoves
  
  ...erono, a global division of Merck KGaA focused on biopharmaceuticals. She also had a nearly 15-year career at Bristol-Myers Squibb, ultimately serving in the role of Senior Vice President and Head of Global Medical Affai...
  Read Full Article
  
  Comment
  
  Mentions: IPO acquisition Bristol-Myers Squibb
7. Bristol-Myers CEO Giovanni Caforio Nets $18.7M in 2017 Pay, a 10% Raise
  
  Explore Pharma News Mar 28 2018 BoardNews
  
  ...rst half while many other drugmakers posted gains. In the second half, the stock rebounded, however. RELATED: Bristol-Myers Squibb beats Street revenue, EPS estimates in Q4 as Eliquis surges Last month, BMS reported that...
  Read Full Article
  
  Comment
  
  Mentions: Executive Compensation Bristol-Myers Squibb risk
8. Investors in AbbVie, Lilly, Amgen and More Set to Vote on Executive Pay, drug pricing
  
  Explore Pharma News Mar 26 2018 BoardNews
  
  ... Interfaith Center on Corporate Responsibility, which filed the resolutions last year. AbbVie, Amgen, Biogen, Bristol-Myers Squibb and Eli Lilly shareholders now have the right to vote on them, ICCR said. The group has b...
  Read Full Article
  
  Comment
  
  Mentions: Executive Compensation Investment Investors
9. NY State Common to Oppose all Board Directors at Companies Without women members
  
  Explore Pensions & Investments Mar 21 2018 BoardNews
  
  ... "highly qualified" women and minority group members for consideration as corporate directors. In the case of Bristol-Myers Squibb, for example, the pension fund had requested for a commitment to greater board diversity....
  Read Full Article
  
  Comment
  
  Mentions: Diversity Corporate Governance Bristol-Myers Squibb
10. Epizyme Appoints Oncology Industry Leader Michael Giordano, MD, to its Board of Directors
  
  Explore NASDAQ Stock Market Mar 12 2018 BoardMoves
  
  ...st recently, Dr. Giordano was senior vice president and head of development, oncology and immuno-oncology for Bristol-Myers Squibb (BMS). In this role, he was responsible for the development strategy for this therapeutic...
  Read Full Article
  
  Comment
  
  Mentions: Investors SEC Nasdaq
11. Bristol-Myers Squibb Names José Baselga, MD, Ph.D. to Board of Directors
  
  Explore BMS Newsroom Mar 2 2018 BoardMoves
  
  ...ristol-Myers Squibb. “His knowledge across cancer biology and drug development will bring tremendous value to Bristol-Myers Squibb, and we look forward to working together to advance new therapies for patients.” “Bristol...
  Read Full Article
  
  Comment
  
  Mentions: Technology Twitter Bristol-Myers Squibb
12. Surface Oncology Expands Board of Directors
  
  Explore businesswire.com Feb 22 2018 BoardMoves
  
  ...entific Advisory Board since 2014. Previously, he served as chief scientific officer and president of R&D for Bristol-Myers Squibb (BMS) where 14 new medicines were brought to market under his leadership. Among these was...
  Read Full Article
  
  Comment
  
  Mentions: CFO Bristol-Myers Squibb Harvard
13. Catalent Announces Changes to its Board of Directors
  
  Explore businesswire.com Feb 20 2018 BoardMoves
  
  ...roup of Companies, ending as Company Group Chairman, OTC and Nutritional Group. From 1982 to 2002, she was at Bristol-Myers Squibb Company, ending her tenure there as President, U.S. Primary Care. Ms. Crane received her ...
  Read Full Article
  
  Comment
  
  Mentions: Management Bristol-Myers Squibb Edge Therapeutics
14. Arcus Biosciences Appoints David Beier to Board of Directors
  
  Explore businesswire.com Dec 18 2017 BoardMoves
  
  ...as founded in 2015 by Terry Rosen and Juan Jaen, the co-founders of Flexus Biosciences, which was acquired by Bristol-Myers Squibb in 2015 to access Flexus’s IDO inhibitor, which was in preclinical development at the tim...
  Read Full Article
  
  Comment
  
  Mentions: Technology Bristol-Myers Squibb Amgen
15. Jamieson Wellness Inc. Rounds Out Independent Board of Industry-Leading Experts
  
  Explore businesswire.com Oct 30 2017 BoardMoves
  
  ...armaceuticals, medical/healthcare and nutritional CPGs. During her career she has helped companies, including Bristol-Myers Squibb and Mead Johnson Nutrition accelerate growth and build shareholder value through discipli...
  Read Full Article
  
  Comment
  
  Mentions: Investor Relations Technology Audit Committee
16. CytomX Therapeutics Appoints Charles S. Fuchs, Md, Mph to Board of Directors
  
  Explore NASDAQ Stock Market Oct 24 2017 BoardMoves
  
  ...thy tissue. In addition to its wholly owned programs, CytomX has strategic collaborations with AbbVie, Amgen, Bristol-Myers Squibb Company, Pfizer Inc., MD Anderson Cancer Center and ImmunoGen, Inc. For more information,...
  Read Full Article
  
  Comment
  
  Mentions: SEC Twitter Nasdaq
17. Edge Therapeutics Appoints Rosemary A. Crane, Pharmaceutical Industry Leader, to its Board of ...
  
  Explore NASDAQ Stock Market Sep 19 2017 BoardMoves
  
  ...e President of Global Marketing for the Pharmaceutical Group. Ms. Crane has also served in executive roles at Bristol-Myers Squibb, including President of U.S. Primary Care and President of Global Marketing and Consumer ...
  Read Full Article
  
  Comment
  
  Mentions: Nasdaq Bristol-Myers Squibb Edge Therapeutics
18. Myers Squibb Names Karen Vousden, Ph.D. to Board of Directors
  
  Explore BMS Newsroom Sep 13 2017 BoardMoves
  
  ...ompany (NYSE:BMY) today announced that its Board of Directors has elected Karen... NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) today announced that its Board of Directors has elected Karen Vousden,...
  Read Full Article
  
  Comment
  
  Mentions: Technology Twitter Karen Vousden
19. 1-17 of 17